FLS
65
4
EQR
28
-8
AVY
55
2
PBI
55
2
EMN
56
-2
MUR
42
3
DHR
70
2
AON
52
-6
GPC
66
5
NWSA
55
-15
MCK
66
2
MNST
62
2
LOW
53
5
VRSK
39
2
ZBH
62
-3
PEG
32
3
QRVO
50
-3
WY
62
8
CTAS
39
2
RHI
47
2
FLS
65
4
EQR
28
-8
AVY
55
2
PBI
55
2
EMN
56
-2
MUR
42
3
DHR
70
2
AON
52
-6
GPC
66
5
NWSA
55
-15
MCK
66
2
MNST
62
2
LOW
53
5
VRSK
39
2
ZBH
62
-3
PEG
32
3
QRVO
50
-3
WY
62
8
CTAS
39
2
RHI
47
2
Financhill
Back

Collegium Pharmaceutical, Inc. Stock Predictions

Meet America's Newest $1B Unicorn

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
70

COLL
Collegium Pharmaceutical, Inc.

Last Price:
$45.58
Seasonality Move:
-1.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Exxon and Chevron Have an Unlikely New Competitor

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

Collegium Pharmaceutical, Inc. Stock Forecast

  • Over the next 52 weeks, Collegium Pharmaceutical, Inc. has on average historically risen by 9% based on the past 10 years of stock performance.
  • Collegium Pharmaceutical, Inc. has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Collegium Pharmaceutical, Inc. Stock Undervalued?
    The current Collegium Pharmaceutical, Inc. [COLL] share price is $45.54. The Score for COLL is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • COLL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Collegium Pharmaceutical, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Collegium Pharmaceutical, Inc. has on average historically risen by 9% based on the past 10 years of stock performance.

Collegium Pharmaceutical, Inc. Stock Rating

Buy
70
Collegium Pharmaceutical, Inc. (COLL) is a Buy

Is Collegium Pharmaceutical, Inc. overpriced?

  • Collegium Pharmaceutical, Inc. has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Collegium Pharmaceutical, Inc. Stock Price History

Is COLL stock going to rise?

  • The current trend is moderately bearish and COLL is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
collegiumpharma.com

52-Week Data

52-Week High:
50.79
52-Week Low:
23.23

Prediction Charts

Market Cap:
1.4B
Price in USD:
45.54
Volume:
675.1K
Beta:
0.80

Technical Analysis

SMA50:
45.31
SMA100:
40.66
SMA200:
35.27
52-Wk Change:
36.59%

Stock Predictions

  • Is Collegium Pharmaceutical, Inc. stock public?
    Yes, Collegium Pharmaceutical, Inc. is a publicly traded company.
  • What is the Collegium Pharmaceutical, Inc. stock quote today?
    The Collegium Pharmaceutical, Inc. stock price is 45.54 USD today.
  • How to buy Collegium Pharmaceutical, Inc. stock online?
    You can buy Collegium Pharmaceutical, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-18 48.99 49.33 49.92 48.87
Dec-19 48.78 48.88 49.79 48.53
Dec-22 48.77 48.84 49.20 48.29
Dec-23 49.01 48.85 49.45 48.63
Dec-24 48.91 49.58 49.59 48.50
Dec-26 49.77 49.84 50.01 49.09
Dec-29 50.08 49.48 50.79 49.21
Dec-30 49.49 47.13 49.49 46.86
Dec-31 46.78 46.30 47.44 45.80
Jan-5 45.17 45.68 45.82 44.51
Jan-6 45.81 46.21 47.55 45.66
Jan-7 46.71 47.26 47.68 45.95
Jan-8 47.73 48.78 49.17 47.21
Jan-9 48.77 45.54 49.04 45.01

Collegium Pharmaceutical, Inc. Earnings

Collegium Pharmaceutical, Inc. Earnings Report: Per Share Collegium Pharmaceutical, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Collegium Pharmaceutical, Inc. Forecast Revenue Growth

Collegium Pharmaceutical, Inc. Stock Analysis: Historical quarterly revenues per share for Collegium Pharmaceutical, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and a decrease next year of $2.36 per share.

* Collegium Pharmaceutical, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.